Literature DB >> 20472152

Alteplase for ischaemic stroke--much sooner is much better.

Jeffrey L Saver1, Steven R Levine.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20472152     DOI： 10.1016/S0140-6736(10)60634-4

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  19 in total

1.  Access to hyperacute stroke services across Canadian provinces: a geospatial analysis.

Authors:  Prasanna Venkatesan Eswaradass; Richard H Swartz; Jamey Rosen; Michael D Hill; M Patrice Lindsay
Journal:  CMAJ Open       Date:  2017-06-14

Review 2.  Cytoprotective protein C pathways and implications for stroke and neurological disorders.

Authors:  Berislav V Zlokovic; John H Griffin
Journal:  Trends Neurosci       Date:  2011-02-25       Impact factor: 13.837

Review 3.  [Time is brain : Time management in acute stroke treatment].

Authors:  S Behnke
Journal:  Radiologe       Date:  2019-07       Impact factor: 0.635

4.  An activated protein C analog with reduced anticoagulant activity extends the therapeutic window of tissue plasminogen activator for ischemic stroke in rodents.

Authors:  Yaoming Wang; Zhenggang Zhang; Nienwen Chow; Thomas P Davis; John H Griffin; Michael Chopp; Berislav V Zlokovic
Journal:  Stroke       Date:  2012-07-17       Impact factor: 7.914

5.  Post-insult valproate treatment potentially improved functional recovery in patients with acute middle cerebral artery infarction.

Authors:  Jiunn-Tay Lee; Chung-Hsing Chou; Nai-Yu Cho; Yueh-Feng Sung; Fu-Chi Yang; Cheng-Yu Chen; Yu-Hua Lai; Chun-I Chiang; Chi-Ming Chu; Jiann-Chyun Lin; Yaw-Don Hsu; Jau-Shyong Hong; Giia-Sheun Peng; De-Maw Chuang
Journal:  Am J Transl Res       Date:  2014-11-22       Impact factor: 4.060

6.  The 2012 Feinberg Lecture: treatment swift and treatment sure.

Authors:  Jeffrey L Saver
Journal:  Stroke       Date:  2012-12-13       Impact factor: 7.914

7.  Activated protein C analog protects from ischemic stroke and extends the therapeutic window of tissue-type plasminogen activator in aged female mice and hypertensive rats.

Authors:  Yaoming Wang; Zhen Zhao; Nienwen Chow; Padmesh S Rajput; John H Griffin; Patrick D Lyden; Berislav V Zlokovic
Journal:  Stroke       Date:  2013-10-24       Impact factor: 7.914

8.  Neurohospitalists Improve Door-to-Needle Times for Patients With Ischemic Stroke Receiving Intravenous tPA.

Authors:  Archit Bhatt; Ahmed Shatila
Journal:  Neurohospitalist       Date:  2012-10

9.  Tissue at risk in acute stroke patients treated beyond 8 h after symptom onset.

Authors:  C Leiva-Salinas; A Aghaebrahim; G Zhu; J T Patrie; W Xin; B C Lau; T Jovin; M Wintermark
Journal:  Neuroradiology       Date:  2013-04-05       Impact factor: 2.804

10.  Rapid Short MRI Sequence Useful in Eliminating Stroke Mimics Among Acute Stroke Patients Considered for Intravenous Thrombolysis.

Authors:  Stephanie Paolini; Joselyn Burdine; Michael Verenes; James Webster; Theodore Faber; Cole Blease Graham; Souvik Sen
Journal:  J Neurol Disord       Date:  2013-10-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.